Patents by Inventor Daniel H. Lange

Daniel H. Lange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11934212
    Abstract: A handheld computer device is configured to selectively receive a plurality of fluid output values from a paint sprayer and configured to operate in an accessible mode in which the handheld computer device is in a first location where wireless connectivity, via a continuous or near continuous communication path, to at least one of a network server or the paint sprayer is accessible or operate in an inaccessible mode in which the handheld computer device is in a second location out of range of the continuous or near continuous communication path to at least one of the network server or the paint sprayer.
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: March 19, 2024
    Assignee: GRACO MINNESOTA INC.
    Inventors: Christopher M. Lange, Nicholas A. Pagano, Benjamin R. Godding, Mark T. Weinberger, Michael J. Mansheim, Nicholas H. Reath, Andrew J. Kopel, Daniel R. Johnson, Kevin C. Robb, Robert J. Gundersen
  • Patent number: 11934210
    Abstract: A handheld computer device is configured to selectively receive a plurality of fluid output values from a paint sprayer and configured to operate in an accessible mode in which the handheld computer device is in a first location where wireless connectivity, via a continuous or near continuous communication path, to at least one of a network server or the paint sprayer is accessible or operate in an inaccessible mode in which the handheld computer device is in a second location out of range of the continuous or near continuous communication path to at least one of the network server or the paint sprayer.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: March 19, 2024
    Assignee: GRACO MINNESOTA INC.
    Inventors: Christopher M. Lange, Nicholas A. Pagano, Benjamin R. Godding, Mark T. Weinberger, Michael J. Mansheim, Nicholas H. Reath, Andrew J. Kopel, Daniel R. Johnson, Kevin C. Robb, Robert J. Gundersen
  • Patent number: 11931155
    Abstract: Provided are systems for measuring an electrocardiogram (ECG) using a wearable device. An example system includes the wearable device. The wearable device has a means for recording an electrical signal from a single wrist of a patient. The wearable device also has a means for detecting a pulse of the patient and recording a photoplethysmogram (PPG) signal, via a PPG optical sensor associated with the wearable device. The wearable device further has a means for generating the electrical signal segments being time-locked to the PPG signal by utilizing the PPG signal as a reference signal. Furthermore, the wearable device has a means for summing the electrical signal segments in a given time period and dividing by the number of segments to produce an average ECG waveform.
    Type: Grant
    Filed: March 28, 2023
    Date of Patent: March 19, 2024
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Patent number: 11934211
    Abstract: A handheld computer device is configured to selectively receive a plurality of fluid output values from a paint sprayer and configured to operate in an accessible mode in which the handheld computer device is in a first location where wireless connectivity, via a continuous or near continuous communication path, to at least one of a network server or the paint sprayer is accessible or operate in an inaccessible mode in which the handheld computer device is in a second location out of range of the continuous or near continuous communication path to at least one of the network server or the paint sprayer.
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: March 19, 2024
    Assignee: GRACO MINNESOTA INC.
    Inventors: Christopher M. Lange, Nicholas A. Pagano, Benjamin R. Godding, Mark T. Weinberger, Michael J. Mansheim, Nicholas H. Reath, Andrew J. Kopel, Daniel R. Johnson, Kevin C. Robb, Robert J. Gundersen
  • Publication number: 20240065563
    Abstract: Systems and methods for blood pressure measurement (BP) based on photoplethysmogram (PPG) data and electrocardiogram (ECG) data an initial baseline BP from a reliable source. A force is cyclically applied to a PPG sensor and the PPG pulse data is recorded and analyzed to determine a PPG-pulse-peak value. The initial baseline MAP is used to configure a MAP model. Additionally, a pre-determined PTT model utilizing PPG and ECG data along blood vessel parameters and baseline BP are initialized to generate a BP. Subsequent BP measurements use the same process of determining PPG-pulse-peak values, the initialize MAP model and pre-determined PTT model to determine a new BP value.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 29, 2024
    Inventor: Daniel H. Lange
  • Patent number: 11712190
    Abstract: Provided are a method and systems for measuring an electrocardiogram (ECG) using a wearable device. An example system includes the wearable device in a shape of a band worn on a limb (e.g., a wrist) of a patient. The wearable device includes an electrical sensor. The wearable device is operable to record, via the at least one electrical sensor, an electrical signal from the limb of the patient. The wearable device is operable to split the electrical signal into segments based on a reference signal. The reference signal includes an indication of onset times of heart beats. The segments are averaged to derive average ECG data of low signal-to-noise ratio. The wearable device includes an optical sensor operable to measure skin color beneath a pulsating artery of the limb. The reference signal includes a photoplethysmogram (PPG) signal recorded via the optical sensor simultaneously with the electrical signal.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: August 1, 2023
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Publication number: 20230233129
    Abstract: Provided are systems for measuring an electrocardiogram (ECG) using a wearable device. An example system includes the wearable device. The wearable device has a means for recording an electrical signal from a single wrist of a patient. The wearable device also has a means for detecting a pulse of the patient and recording a photoplethysmogram (PPG) signal, via a PPG optical sensor associated with the wearable device. The wearable device further has a means for generating the electrical signal segments being time-locked to the PPG signal by utilizing the PPG signal as a reference signal. Furthermore, the wearable device has a means for summing the electrical signal segments in a given time period and dividing by the number of segments to produce an average ECG waveform.
    Type: Application
    Filed: March 28, 2023
    Publication date: July 27, 2023
    Inventor: Daniel H. Lange
  • Publication number: 20230157572
    Abstract: A continuous and self-calibration method and system for monitoring oxygen saturation of a patient are provided. An example system includes a wearable device having a first optical sensor to measure a first red wavelength photoplethysmography (PPG) signal and a first infrared wavelength PPG signal and a second optical sensor to measure a second red wavelength PPG signal and a second infrared wavelength PPG signal. The system further includes a processor configured to repeatedly determine that conditions for recalibration of the first optical sensor are satisfied, determine a first ratio for obtaining the oxygen saturation, a first parameter for modifying the first red wavelength PPG signal, a second parameter for modifying the first infrared wavelength PPG signal, and a second ration for obtaining the oxygen saturation. The processor is further configured to determine a value of the oxygen saturation and provide a message regarding a health status of the patient.
    Type: Application
    Filed: January 23, 2023
    Publication date: May 25, 2023
    Inventor: Daniel H. Lange
  • Publication number: 20230040540
    Abstract: Systems and methods for optimizing sensor pressure in blood pressure (BP) measurements using a wearable device are provided. An example method includes recording substantially synchronously photoplethysmogram (PPG) data using a PPG sensor and pressure data using at least one pressure sensor on a wearable device, the wearable device having the PPG sensor, and wherein the at least one pressure sensor is substantially located over a user wrist radial artery while an external force gradually applies and releases pressure a plurality of times to the wearable device, wherein the external force is applied to the radial artery. The PPG data and the pressure data is monitored as the PPG data changes in response to the external force being applied and released multiple times during a period. From the recorded PPG and pressure data, a set data us formed of PPG peak values and pressure values. A curve is fitted through the data set. From the curves apex value a MAP value is determined.
    Type: Application
    Filed: October 18, 2022
    Publication date: February 9, 2023
    Inventor: Daniel H. Lange
  • Patent number: 11571139
    Abstract: A method and system for monitoring oxygen saturation of a patient are provided. An example system includes a wearable device having a first optical sensor to measure a first red wavelength photoplethysmography (PPG) signal and a first infrared wavelength PPG signal and a second optical sensor to measure a second red wavelength PPG signal and a second infrared wavelength PPG signal. The system further includes a processor configured to determine that conditions for calibration of the first optical sensor are satisfied, determine a first ratio for obtaining the oxygen saturation, a first parameter for modifying the first red wavelength PPG signal, a second parameter for modifying the first infrared wavelength PPG signal, and a second ratio for obtaining the oxygen saturation. The processor is further configured to determine a value of the oxygen saturation and provide a message regarding a health status of the patient.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: February 7, 2023
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Publication number: 20230007922
    Abstract: A method and system are provided for estimating a physiological parameter using a parameter model determined by a deep neural network. An example method includes training a deep neural network with indirect and direct physiological parameters from a user database. The medical parameters include a respiratory rate, oxygen saturation, temperature, blood pressure, and pulse rate. The method includes determining if a new user belongs in a group. If the parameter model estimated physiological parameter using the closest group to the new user and associated calibration, then the method quantizes the parameter inputs to determine which physiological parameter a new user is most sensitive and to determine a new group and calibration coefficients or curves for the new user.
    Type: Application
    Filed: August 31, 2022
    Publication date: January 12, 2023
    Inventor: Daniel H. Lange
  • Patent number: 11464457
    Abstract: A method and systems for determining an early warning score for a health status of a patient are provided. An example method includes acquiring, during a predetermined time period via sensors integrated into a wearable device worn on a wrist of the patient, initial values of medical parameters of patient. The medical parameters include a respiratory rate, oxygen saturation, temperature, blood pressure, and pulse rate, and level of consciousness. The method includes determining, based on the initial values, normal values of the medical parameters. The method includes acquiring, via the sensors and at a pre-determined frequency, further values of the medical parameters. The method includes determining, based on deviations of the further values from the normal values, individual scores for the medical parameters. The method includes calculating, based on the individual scores, a general score. The method includes determining, based on the general score, the health status of the patient.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: October 11, 2022
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Publication number: 20210401313
    Abstract: Systems and methods for optimizing sensor pressure in blood pressure (BP) measurements using a wearable device are provided. An example method includes recording photoplethysmogram (PPG) data using a PPG sensor of a wearable device while a pressure applied by the PPG sensor to a blood artery of a user is gradually increasing, monitoring a pulsating parameter associated with the PPG data, determining that the pulsating parameter has passed a critical value, in response to the determination, causing the increase of the pressure to stop, recording further PPG data using the PPG sensor and electrocardiogram (ECG) data using input plates of the wearable device, analyzing the further PPG data and the ECG data to determine a pulse transit time (PTT), a pulse rate (PR), and a diameter parameter, and determining, using a pre-defined model, a BP based on the PTT, the PR, and the diameter parameter.
    Type: Application
    Filed: August 31, 2021
    Publication date: December 30, 2021
    Inventor: Daniel H. Lange
  • Patent number: 11160459
    Abstract: Methods and systems for monitoring health status of chronically ill people are provided. An example system includes a wearable device with sensors, with the wearable device being designed to be worn on a wrist of a patient. The wearable device is operable to continuously collect, via sensors, sensor data from a single place on body of the patient. The sensor data are processed to obtain electrocardiogram data and photoplethysmogram data. The electrocardiogram data and the photoplethysmogram data are analyzed to obtain medical parameters associated with a chronic disease. Based at least partially on the changes in the medical parameters over time, a progression of the at least one chronic disease can be determined. Based on the progression, messages regarding the current health condition are sent to the patient. The messages include advice to take medicine or contact a medical professional if a chronic condition is worsening.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: November 2, 2021
    Assignee: ChroniSense Medical Ltd.
    Inventors: Yossi Gross, Daniel H. Lange
  • Patent number: 11160461
    Abstract: Systems and methods for performing a blood pressure measurement are provided. An example method includes simultaneously recording, by a wearable device, an electrocardiogram (ECG) and photoplethysmogram (PPG). PPG is measured at a blood artery. The method also includes analyzing ECG and PPG to determine a pulse transit time (PTT), a pulse rate (PR), and a diameter parameter. The diameter parameter includes a diameter of the blood artery or a change thereof. The method also includes determining, based on PTT, PR, and the diameter parameter, a blood pressure (BP) using a pre-defined model. The pre-defined model establishes a relationship between PTT, PR, the diameter parameter, and BP. The pre-defined model may be trained using statistical data obtained in a calibration process. The statistical data includes PTT, PR, and the diameter parameter measured with the wearable device and corresponding values of BP measured with an external device.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: November 2, 2021
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Publication number: 20210145310
    Abstract: A method and system for monitoring oxygen saturation of a patient are provided. An example system includes a wearable device having a first optical sensor to measure a first red wavelength photoplethysmography (PPG) signal and a first infrared wavelength PPG signal and a second optical sensor to measure a second red wavelength PPG signal and a second infrared wavelength PPG signal. The system further includes a processor configured to determine that conditions for calibration of the first optical sensor are satisfied, determine a first ratio for obtaining the oxygen saturation, a first parameter for modifying the first red wavelength PPG signal, a second parameter for modifying the first infrared wavelength PPG signal, and a second ratio for obtaining the oxygen saturation. The processor is further configured to determine a value of the oxygen saturation and provide a message regarding a health status of the patient.
    Type: Application
    Filed: January 20, 2021
    Publication date: May 20, 2021
    Inventor: Daniel H. Lange
  • Patent number: 11000235
    Abstract: Provided are methods and systems for monitoring cardiac function. A series of heartbeat waveforms is collected during a pre-determined time period. The series is collected either from an individual or a plurality of individuals. A heartbeat waveform space is generated based on the series of heartbeat waveforms. A test heartbeat waveform is projected onto the heartbeat waveform space. The projected heartbeat waveform is subtracted from the test heartbeat waveform to obtain a pathology descriptive deflections (PDD) vector. A score is calculated based on the PDD vector. Based on the score, a clinical indication associated with at least one disease is provided. The clinical indication includes a warning message regarding an upcoming cardiac episode or a measure of progression or regression of at least one cardiac pathology.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: May 11, 2021
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Patent number: 10952638
    Abstract: A method and system for monitoring respiratory rate of a patient is provided. An example system includes a wearable device configured to be disposed around a wrist of the patient. The wearable device may include a gyroscope to measure a gyroscope signal indicative of a motion of the patient. The system may further include a processor communicatively coupled to the gyroscope. The processor can be configured to perform a spectral analysis of the gyroscope signal to obtain a spectrum in a pre-determined range. The pre-determined range may cover a normal respiratory rate range. The processor can be further configured to determine a position of a peak in the spectrum to obtain a value for the respiratory rate. The processor can be further configured to provide, based on the value of the respiratory rate, a message regarding a health status of the patient.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: March 23, 2021
    Assignee: ChroniSense Medical Ltd.
    Inventor: Daniel H. Lange
  • Patent number: 10687742
    Abstract: An example method for performing pulse oximetry can commence with receiving at least three light signals of three different wavelengths reflected from a human tissue. The human tissue includes a pulsatile tissue and a non-pulsatile tissue. Based on the three light signals, values of at least three functions are determined. The three functions are invariant to an oxygen saturation in the pulsatile tissue and depend on location of a sensor operable to detect the three light signals and pressure of the sensor on the human tissue. Based on the values of the three functions, non-pulsatile components are analyzed for intensities of a red light signal and infrared light signal reflected from the human tissue. The non-pulsated components are removed from the intensities to allow correct estimates of a ratio of the absorption coefficients, with the ratio being used to determine the oxygen saturation in the pulsatile tissue.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: June 23, 2020
    Assignee: ChroniSense Medical Ltd.
    Inventors: Daniel H. Lange, Boris Karelin
  • Patent number: 10470692
    Abstract: Provided are a method and systems for performing pulse oximetry. A light signal is emitted for a period of time and a modulated light signal is detected. The modulated light signal includes a red signal and an infrared signal. The modulated light signal is originated by an interaction of the light signal with a pulsatile tissue and a non-pulsatile tissue. The modulated light signal is processed to estimate an oxygen saturation in the pulsatile tissue during the period of time. The processing includes removing a non-pulsatile component resulting from the interaction of the light signal and the non-pulsatile tissue. The non-pulsatile component can be removed by removing a first parameter from an intensity of the infrared signal and a second parameter from an intensity of the red signal. The parameters are pre-determined using a calibration process to reproduce a true value for a ratio used to determine the oxygen saturation.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: November 12, 2019
    Assignee: ChroniSense Medical Ltd.
    Inventors: Daniel H. Lange, Boris Karelin